Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternating Chemoradiotherapy For Nasopharyngeal Cancer Using Cisplatin And 5-Fluorouracil
NCT00093665Phase 2Unknown
- Sponsor
- Aichi Cancer Center
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC), sponsored by Aichi Cancer Center. Primary endpoint: Progression-Free Survival at 3 years. Status: unknown.
02
Drugs
cisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00093665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093665.